Health Canada has successfully obtained a permanent injunction against Quebec-based online retailer Canlab Research, effectively prohibiting the company from selling unauthorized injectable peptides across Canada. The agency cited the company's history of marketing these unapproved drugs with unsubstantiated health claims, despite prior warnings and enforcement actions.

Canlab Research Sold Unauthorized Injectable Peptides

The legal action follows an urgent warning issued to consumers in December 2023, advising against the purchase of injectable peptides from Canlab Research due to significant health risks. Health Canada had previously issued a ministerial order compelling the company to halt the advertisement and sale of these unauthorized health products, emphasizing the potential dangers to public health.

Under the terms of the injunction, Canlab Research and its associates are now legally prevented from manufacturing, testing, distributing, or selling unauthorized injectable peptides. Furthermore, the company is prohibited from aiding any other entity in these activities, including the advertisement of such products through any digital platform accessible within Canada.

Risks Associated with Unauthorized Peptides

Injectable peptides are substances that influence bodily functions and are commonly marketed for purposes such as bodybuilding, anti-aging treatments, and athletic performance enhancement. In Canada, these compounds are classified as prescription drugs and require specific authorization from Health Canada before they can be legally sold to the public. This regulatory framework is designed to ensure product safety and efficacy.

A prior advisory from Health Canada in April urged Canadians to exercise extreme caution regarding peptides purchased online, highlighting that these products can alter physiological processes. These substances are frequently promoted on social media and the internet for a range of purported benefits including weight loss, improved sleep, enhanced mental focus, and general wellness. However, the agency stressed that the advertised benefits are often unproven.

The health risks associated with the consumption of unauthorized peptides can be severe and wide-ranging. According to Health Canada, these potential adverse effects may include:

  • Hormonal imbalance
  • Mood swings
  • Blood sugar fluctuations
  • Liver or kidney damage
  • Blood clots
  • Development of cancerous tumours

Consumers seeking to ensure the legitimacy of pharmaceutical products in Canada are advised to look for an eight-digit Drug Identification Number (DIN) prominently displayed on product labels. A comprehensive list of authorized drugs is also available through Health Canada's Drug Product Database, allowing individuals to verify the regulatory status of medications before purchase or use.